Single-cell Analysis Market Report 2026

Single-cell Analysis Market Overview

• Single-cell Analysis market size has reached to $3.93 billion in 2025 • Expected to grow to $8.21 billion in 2030 at a compound annual growth rate (CAGR) of 16% • Growth Driver: Rising Significance Of Personalized Medicine Propelling Growth In The Single-Cell Analysis Market • Market Trend: Advancements in Single-Cell Technology Enhancing The Single-Cell Analysis Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-cell Analysis Market?

Single-cell analysis is the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the level of a single cell. It helps in standardizing and automating the workflows with information useful in the treatment of various diseases such as cancer. The single-cell analysis is engaged in conducting research and experimental development in single-cell analysis. The main types of single-cell analysis are consumables and instruments. Consumables are used in exosome analysis, research and genetic exploration, and isolation of RNA and DNA. The workflow of single-cell analysis is single-cell isolation & library preparation, downstream analysis, and data analysis using techniques such as flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, and other techniques. There are various applications of single-cell analysis such as cancer, immunology, neurology, stem cells, non-invasive prenatal diagnosis, in-vitro fertilization, and other applications. The end-users are academic and research laboratories, biotechnology and pharmaceutical companies, and hospital and diagnostic laboratories.

What Is The Single-cell Analysis Market Growth Forecast?

The single-cell analysis market size is expected to see rapid growth in the next few years. It will grow to $8.21 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing investments in precision medicine, expansion of single-cell applications in drug discovery, rising use in clinical research, growing adoption of ai-driven biological analysis, increasing demand for personalized therapeutics. Major trends in the forecast period include increasing adoption of high-throughput single-cell sequencing, rising integration of multi-omics analysis, growing use of ai in cell data interpretation, expansion of automated single-cell workflows, enhanced focus on translational research.

Global Single-cell Analysis Market Segmentation

1) By Product: Consumables, Instruments 2) By Workflow: Single-Cell Isolation And Library Preparation, Downstream Analysis, Data Analysis 3) By Technique: Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques 4) By Application: Cancer, Immunology, Neurology, Stem Cell, Non-invasive prenatal diagnosis, In-Vitro fertilization, Other Applications 5) By End User: Academic and Research Laboratories, Biotechnology And Pharmaceutical Companies, Hospital And Diagnostic Laboratories Subsegments: 1) By Consumables: Reagents, Kits, Assay Plates And Containers, Microfluidic Chips 2) By Instruments: Flow Cytometers, Cell Sorters, Microscopes, Imaging Systems, Single-Cell Sequencers

What Is The Driver Of The Single-cell Analysis Market?

The growing focus on personalized medicine across the globe is contributing to the growth of the single-cell analysis market. Personalized medicine is a medical practice that uses a genetic profile of a particular individual to make decisions for the treatment of a disease and also for the prevention and diagnosis of the disease for that specific individual. The single-cell analysis could help in the treatment of various diseases by giving deep insights into the needs of individual patients, the nature of the disease, and the personalized treatment for it. Thus, more patients are opting for personalized medicines for themselves. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Hence, the increasing focus on personalized medicine is supporting the growth of the market.

Key Players In The Global Single-cell Analysis Market

Major companies operating in the single-cell analysis market include Becton Dickinson and Company, Merck KGAA, QIAGEN N. V., Thermo Fisher Scientific Inc., Illumina Inc., Standard BioTools Inc., 10X Genomics Inc., Bio-Rad Laboratories Inc., Novogene Corporation Limited, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences Inc., Oxford Nanopore Technologies Ltd., 1CellBio Inc., 3D Biomatrix Inc., ACEA Biosciences Inc., Akoya Biosciences Inc., Berkeley Lights Inc., Bio-Techne Corporation, Celsee Inc., Cellular Research Inc., Cytena GmbH, Dolomite Bio Limited, Drop-seq Technologies Inc., Epic Sciences Inc., Ginkgo Bioworks Inc., IsoPlexis Corporation, Menarini Silicon Biosystems S. p. A., Mission Bio Inc., NanoCellect Biomedical Inc., NemaMetrix Inc., OnRamp Bioinformatics Inc., Partek Incorporated, RareCyte Inc., Scienion AG, SeqWell Inc., Sphere Fluidics Limited, Takara Bio USA Holdings Inc.

Global Single-cell Analysis Market Trends and Insights

Major companies in the single-cell analysis market are prioritizing the development of advanced clinical diagnostic tools such as high-precision single-cell RNA-sequencing kits to improve the accuracy and depth of gene-expression analysis. High-precision single-cell RNA-sequencing kits are specialized tools designed to accurately capture and analyze gene expression from individual cells, helping researchers uncover cellular diversity, identify rare cell types, and gain deeper insights into biological processes and disease mechanisms. For example, in June 2024, Bio-Rad, a US-based leader in life science research and clinical diagnostics, launched Single-Cell 3’ RNA-Seq Kit for single cell gene expression, the Single-Cell 3’ RNA-Seq Kit is a specialized tool designed for high-throughput sequencing of gene expression from individual cells. This kit focuses on capturing the 3' end of mRNA transcripts, allowing researchers to analyze and quantify gene expression profiles in single cells. It is widely used in studies of cellular heterogeneity, developmental biology, and disease mechanisms, providing valuable insights into complex biological systems single-cell analysis market.

What Are Latest Mergers And Acquisitions In The Single-cell Analysis Market?

In July 2023, Illumina, Inc., an US-based biotechnology company, acquired Fluent BioSciences for an undisclosed amount. The aim of the acquisition is to improve Illumina's expertise in single-cell analysis and broaden its multiomics growth strategy by incorporating the innovative and accessible technology developed by Fluent BioSciences. Fluent BioSciences is a US-based biotechnology company that specializes in advancing technologies for single-cell analysis, concentrating on developing innovative and scalable solutions that support genomic research and allow researchers to perform in-depth studies at the single-cell level.

Regional Insights

North America was the largest region in the single-cell analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Single-cell Analysis Market?

The single-cell analysis market includes revenues earned by entities by providing services such as antibody-based methods, fluorescent protein-based methods, and mass-spectroscopy based methods. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Single-cell Analysis Market Report 2026?

The single-cell analysis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.